Results 151 to 160 of about 35,299 (221)

Pneumococcal conjugate vaccines and hospitalization of children for pneumonia: a time-series analysis, South Africa, 2006–2014

, 2017
Alane Izu, Fatima Solomon, Susan Nzenze, Azwifarwi Mudau, Elizabeth R. Zell, Katherine L. O’Brien, Cynthia G. Whitney, Jennifer R. Verani, Michelle J. Groome, Shabir A. Madhi   +9 more
openalex   +1 more source

Invasive pneumococcal disease in hospitalised children from Lima, Peru before and after introduction of the 7-valent conjugated vaccine [PDF]

, 2019
Alessandra Luna-Muschi, Franco Castillo Tokumori, Maria Deza Leon, Erik H. Mercado, Martha Egoavil, Katherine Sedano, María E. Castillo, Isabel Reyes, Eduardo Chaparro, Roger Hernández, Winston Roque da Silva, Olguita del Águila, Francisco Campos, A. Saenz, Theresa J. Ochoa   +14 more
openalex   +1 more source

Clinical and evidence-based considerations for choosing a pneumococcal conjugate vaccine in India: A narrative review. [PDF]

Hum Vaccin Immunother
Yewale V, Chatterjee P, Marathe SM, Taur S, Sathyanarayanan S.   +4 more
europepmc   +1 more source

Potential clinical efficacy of the 10-valent pneumococcal-Protein D conjugate vaccine in children with chronic suppurative lung diseases: A double-blind randomised controlled trial [PDF]

, 2016
Kerry-Ann O’Grady, Keith Grimwood, Allan W. Cripps, E. Kim Mulholland, Heidi Smith‐Vaughan, Margie Danchin, Nicholas Wood, Andrew Wilson, Ruth B. Thornton, Paul J. Torzillo, Peter Morris, Peter Richmond, Kirsten P. Perrett, Sheree Rablin, Anne Connor, Vikas Goyal, Tanya Stoney, Anne B. Chang   +17 more
openalex  

Burden of Pneumococcal Disease in Northern Togo before the Introduction of Pneumococcal Conjugate Vaccine

, 2017
Jennifer C. Moïsi, Makawa-Sy Makawa, Haoua Tall, Kodjo Agbenoko, Berthe‐Marie Njanpop‐Lafourcade, Stanislas Tamekloe, Moussa Amidou, Judith E. Mueller, Bradford D. Gessner   +8 more
openalex   +2 more sources

Safety and immunogenicity of a multivalent pneumococcal conjugate vaccine given with 13-valent pneumococcal conjugate vaccine in healthy infants: A phase 2 randomized trial. [PDF]

Hum Vaccin Immunother, 2023
Simon MW, Bataille R, Caldwell NS, Gessner BD, Jodar L, Lamberth E, Peng Y, Scott DA, Lei L, Giardina PC, Gruber WC, Jansen KU, Thompson A, Watson W.   +13 more
europepmc   +1 more source

Comparability of antibody response to a booster dose of 7-valent pneumococcal conjugate vaccine in infants primed with either 2 or 3 doses [PDF]

, 2009
Gerwin D. Rodenburg, Elske J. M. van Gils, Reinier H. Veenhoven, Nienke Jones, Irina Tcherniaeva, Eelko Hak, Loek van Alphen, Guy A. M. Berbers, Elisabeth A. M. Sanders   +8 more
openalex   +1 more source

The impact of 10-valent pneumococcal conjugate vaccine on the incidence of admissions to hospital with hypoxaemic and non-hypoxaemic pneumonia in Kenyan children. [PDF]

PLOS Glob Public Health
Haeusler IL, Kagucia EW, Bottomley C, Otiende M, Nyiro J, Scott JAG.   +5 more
europepmc   +1 more source

Safety and immunogenicity of the 23-valent pneumococcal polysaccharide vaccine at 12 months of age, following one, two, or three doses of the 7-valent pneumococcal conjugate vaccine in infancy

, 2010
Fiona M. Russell, Paul V. Licciardi, Anne Balloch, V. Biaukula, Lisi Tikoduadua, Jonathan R. Carapetis, Jane Nelson, Adam Jenney, Lepani Waqatakirewa, Samantha Colquhoun, Yin Bun Cheung, Mimi L.K. Tang, Kim Mulholland   +12 more
openalex   +2 more sources

Immunogenicity, safety and adverse events of sequential vaccination with a 10-valent pneumococcal conjugate vaccine (PCV10) and PPSV23 compared with PPSV23 alone in systemic lupus erythematosus. [PDF]

Lupus Sci Med
Chatterjee R, Kommaraju SY, Mettingal Ramakrishnan S, Ravikumar KL, Aggarwal A.   +4 more
europepmc   +1 more source